CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, cilt.72, sa.4, ss.407-419, 2019 (SCI-Expanded)
BACKGROUND: Rho-kinase, an effector of the small GTPase RhoA, is known to be a novel inhibitory regulator of eNOS in endothelial cells under basal conditions and disease states. However, although RBC possesses active RhoA/Rho-kinase pathway, Rho-kinase mediated eNOS regulation has not been investigated in RBC, so far.